{
    "id": 19780,
    "fullName": "SEMA4D positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "SEMA4D positive indicates the presence of the SEMA4D gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10507,
        "geneSymbol": "SEMA4D",
        "terms": [
            "SEMA4D",
            "A8",
            "BB18",
            "C9orf164",
            "CD100",
            "coll-4",
            "COLL4",
            "GR3",
            "M-sema-G",
            "SEMAJ"
        ]
    },
    "variant": "positive",
    "createDate": "03/15/2016",
    "updateDate": "01/22/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5042,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, VX15/2503 treatment resulted in decreased T-cell membrane-associated SEMA4D expression, 1 partial response and stable disease in 45.2% (19/42) of patients with advanced solid tumors (PMID: 26446947).",
            "molecularProfile": {
                "id": 20193,
                "profileName": "SEMA4D positive"
            },
            "therapy": {
                "id": 3738,
                "therapyName": "VX15/2503",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4854,
                    "pubMedId": 26446947,
                    "title": "Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26446947"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20193,
            "profileName": "SEMA4D positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}